Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism.

Payer, Juraj; Jackuliak, Peter; Kuzma, Martin; Dzupon, Matús; Vanuga, Peter

Payer, Juraj; Jackuliak, Peter; Kuzma, Martin; Dzupon, Matús; Vanuga, Peter.

Afiliação

Payer J; Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital, Bratislava, Slovakia.
Jackuliak P; Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital, Bratislava, Slovakia.
Kuzma M; Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital, Bratislava, Slovakia.
Dzupon M; Medical Department, Exeltis, Bratislava, Slovakia.
Vanuga P; Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital, Bratislava, Slovakia.

Front Endocrinol (Lausanne) ; 13: 1067029, 2022.

Article em En | MEDLINE | ID: mdl-36465640

Assuntos

Hipotireoidismo; Selênio; Humanos; Feminino; Masculino; Selênio/uso terapêutico; Hipotireoidismo/tratamento farmacológico; Inositol/uso terapêutico; Suplementos Nutricionais; Tireotropina

Palavras-chave

AITDs; Selenium; TSH; hypothyroidism; myo-inositol

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Selênio / Hipotireoidismo Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Eslováquia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google